Exploring the Impact of GLP-1, GIP, and Glucagon Triple Agonism on Energy Expenditure

GLP-1, GIP, and glucagon triple agonism enhances energy expenditure by modulating metabolic pathways related to glucose homeostasis, lipid metabolism, and thermogenesis, as demonstrated in preclinical and clinical studies.

Introduction to GLP-1, GIP, and Glucagon Agonism

The GLP-1, GIP, and glucagon receptors play critical roles in regulating metabolic processes. Triple agonists simultaneously target these receptors, offering a multifaceted approach to metabolic research.

Mechanisms of Energy Expenditure Regulation

Triple agonism increases energy expenditure through enhanced thermogenesis and lipolysis, mediated by central and peripheral mechanisms, as observed in studies like those by Finan et al. (2015).

Preclinical Evidence

Preclinical models have shown that triple agonists significantly increase energy expenditure compared to single or dual agonists, highlighting their potential in metabolic research.

Clinical Trials and Findings

Clinical trials such as SURMOUNT and STEP have provided insights into the effects of triple agonism on energy expenditure in research settings, with promising results noted by Jastreboff et al. (2023).

Future Research Directions

Further research is needed to fully understand the long-term effects and potential applications of triple agonism in energy expenditure regulation.